; and (B) the application contains a detailed 5-year plan for research relating to cannabis. (2) Geographic representation The Director of NIH shall ensure geographic representation across the United States in designating institutions of higher education as Centers of Excellence in Cannabis Research. (3) Term of designation A designation under this section shall be for a period of 5 years. An institution of higher education may reapply in accordance with the requirements under paragraph (1) for a subsequent designation under this section. (b) Cannabis research (1) Grants or cooperative agreements (A) In general The Director of NIH may make grants to, or enter into cooperative agreements with, Centers that have been designated under this section to expand the current and ongoing interdisciplinary research and clinical trials relating to cannabis research. (B) Use of funds Amounts made available under a grant or cooperative agreement under subparagraph (A) may be used to address key questions and gaps in evidence addressed by the national cannabis research agenda described in paragraphs (1) through (5) of section 409K. (2) Research results The Director of NIH shall promptly disseminate research results under this subsection to relevant governmental, academic, and research entities. (c) Definitions In this section: (1) Cannabis The term cannabis has the meaning given the term marihuana in section 102 of the Controlled Substances Act. (2) Institution of higher education The term institution of higher education has the meaning given the term in section 101(a) of the Higher Education Act of 1965. . (b) Registration requirements Section 303(f) of the Controlled Substances Act ( 21 U.S.C. 823(f) ) is amended by adding after the period at the end the following: The Attorney General shall register under this part practitioners at Centers of Excellence in Cannabis Research designated under section 409L of the Public Health Service Act to conduct research with marihuana. No separate registration shall be required for each